AR115865A2 - THERAPEUTIC COMPOUNDS - Google Patents

THERAPEUTIC COMPOUNDS

Info

Publication number
AR115865A2
AR115865A2 ARP190102131A ARP190102131A AR115865A2 AR 115865 A2 AR115865 A2 AR 115865A2 AR P190102131 A ARP190102131 A AR P190102131A AR P190102131 A ARP190102131 A AR P190102131A AR 115865 A2 AR115865 A2 AR 115865A2
Authority
AR
Argentina
Prior art keywords
therapeutic compounds
compound
formula
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
ARP190102131A
Other languages
Spanish (es)
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of AR115865A2 publication Critical patent/AR115865A2/en

Links

Abstract

Reivindicación 1: Un compuesto de formula (1), o una sal farmacéuticamente aceptable del mismo.Claim 1: A compound of formula (1), or a pharmaceutically acceptable salt thereof.

ARP190102131A 2016-08-19 2019-07-29 THERAPEUTIC COMPOUNDS AR115865A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662377312P 2016-08-19 2016-08-19

Publications (1)

Publication Number Publication Date
AR115865A2 true AR115865A2 (en) 2021-03-03

Family

ID=64499920

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP170102299A AR109364A1 (en) 2016-08-19 2017-08-17 ANTIVIRAL COMPOUNDS
ARP190102131A AR115865A2 (en) 2016-08-19 2019-07-29 THERAPEUTIC COMPOUNDS
ARP190103689A AR117709A2 (en) 2016-08-19 2019-12-16 PHARMACEUTICAL COMPOSITION INCLUDING A SUBSTITUTED 1H-INDAZOLE COMPOUND, SAID COMPOUND AND PARENTERAL FORMULATION OF THE SAME

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP170102299A AR109364A1 (en) 2016-08-19 2017-08-17 ANTIVIRAL COMPOUNDS

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP190103689A AR117709A2 (en) 2016-08-19 2019-12-16 PHARMACEUTICAL COMPOSITION INCLUDING A SUBSTITUTED 1H-INDAZOLE COMPOUND, SAID COMPOUND AND PARENTERAL FORMULATION OF THE SAME

Country Status (2)

Country Link
AR (3) AR109364A1 (en)
HR (1) HRP20191601T1 (en)

Also Published As

Publication number Publication date
AR117709A2 (en) 2021-08-25
AR109364A1 (en) 2018-11-21
HRP20191601T1 (en) 2019-11-29

Similar Documents

Publication Publication Date Title
CO2020014586A2 (en) Compounds
CL2019002204A1 (en) HIV inhibitor compounds.
AR108711A1 (en) FXR MODULATING COMPOUNDS (NR1H4)
DOP2020000102A (en) HELPFUL COMPOUNDS TO INHIBIT CDK7
NI201700020A (en) AMINOPYRIMIDINYL COMPOUNDS AS JAK INHIBITORS
PE20151542A1 (en) TETRAHYDROPYRROTHIAZINE COMPOUNDS
EA201791420A1 (en) TRIAZOLOPYRIMIDIN COMPOUNDS AND THEIR APPLICATIONS
AR101995A1 (en) INTEGRINA AVB6 ANTAGONIST COMPOUNDS
ES2721001T3 (en) Isoindoline derivative, and compositions and methods to treat a neurodegenerative disease
AR103680A1 (en) BACE1 SELECTIVE INHIBITORS
AR105821A1 (en) USEFUL COMPOUNDS TO INHIBIT ROR-g-T
AR095097A1 (en) PHENOXYETOXI COMPOUNDS
EA202193015A1 (en) CDK INHIBITORS
MD3395821T2 (en) Antitumoral compounds
CO2018001383A2 (en) Derivatives of n- [pyridin-4-yl] methyl] -4 - {(1r) -1 - [(3s) -3-methyl-2,5-dioxopyrrolidin-3-yl] ethyl} benzamide as antagonists of the cgrp receptor "
SV2016005313A (en) CARBOXAMIDE DERIVATIVES
AR117920A1 (en) HUMAN IMMUNODEFICIENCY VIRUS REPLICATION INHIBITORS
CO2019005165A2 (en) Pyridone compound as c-met inhibitor
CO2019013254A2 (en) 5,6-fused bicyclic compounds and compositions for the treatment of parasitic diseases
DOP2019000021A (en) DERIVED FROM USEFUL TRIAZOLOPIRAZINONE AS A HUMAN PDE1 INHIBITOR
ECSP18038014A (en) SODIUM CHANNEL BLOCKER
AR110770A1 (en) POTASSIUM CHANNEL MODULATORS
PH12021550452A1 (en) Methods of treating mycobacterial infections using tetracycline compounds
AR104241A1 (en) THIAZINE TETRAHYDROFIDE DERIVATIVES AS SELECTIVE BACE1 INHIBITORS
EA202091169A1 (en) SMAC MIMETICS USED AS IAP INHIBITORS AND THEIR APPLICATION